2-206766842-A-G

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001136193.2(FASTKD2):​c.149A>G​(p.Lys50Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00398 in 1,609,052 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0028 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0041 ( 13 hom. )

Consequence

FASTKD2
NM_001136193.2 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:4

Conservation

PhyloP100: 0.611

Publications

6 publications found
Variant links:
Genes affected
FASTKD2 (HGNC:29160): (FAST kinase domains 2) This gene encodes a protein that is localized in the mitochondrial inner compartment and that may play a role in mitochondrial apoptosis. Nonsense mutations have been reported to result in cytochrome c oxidase deficiency. [provided by RefSeq, Oct 2008]
FASTKD2 Gene-Disease associations (from GenCC):
  • mitochondrial disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • combined oxidative phosphorylation deficiency 44
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • FASTKD2-related infantile mitochondrial encephalomyopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0042176247).
BP6
Variant 2-206766842-A-G is Benign according to our data. Variant chr2-206766842-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 376842.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0028 (426/152330) while in subpopulation NFE AF = 0.00467 (318/68032). AF 95% confidence interval is 0.00425. There are 2 homozygotes in GnomAd4. There are 178 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001136193.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FASTKD2
NM_001136193.2
MANE Select
c.149A>Gp.Lys50Arg
missense
Exon 2 of 12NP_001129665.1
FASTKD2
NM_001136194.2
c.149A>Gp.Lys50Arg
missense
Exon 2 of 12NP_001129666.1
FASTKD2
NM_014929.4
c.149A>Gp.Lys50Arg
missense
Exon 2 of 12NP_055744.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FASTKD2
ENST00000402774.8
TSL:1 MANE Select
c.149A>Gp.Lys50Arg
missense
Exon 2 of 12ENSP00000385990.3
FASTKD2
ENST00000236980.10
TSL:1
c.149A>Gp.Lys50Arg
missense
Exon 2 of 12ENSP00000236980.6
FASTKD2
ENST00000403094.3
TSL:5
c.149A>Gp.Lys50Arg
missense
Exon 2 of 12ENSP00000384929.3

Frequencies

GnomAD3 genomes
AF:
0.00279
AC:
424
AN:
152212
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000868
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00118
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00414
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00467
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00263
AC:
652
AN:
248234
AF XY:
0.00259
show subpopulations
Gnomad AFR exome
AF:
0.000744
Gnomad AMR exome
AF:
0.00148
Gnomad ASJ exome
AF:
0.000202
Gnomad EAS exome
AF:
0.000110
Gnomad FIN exome
AF:
0.00445
Gnomad NFE exome
AF:
0.00402
Gnomad OTH exome
AF:
0.00364
GnomAD4 exome
AF:
0.00411
AC:
5980
AN:
1456722
Hom.:
13
Cov.:
32
AF XY:
0.00400
AC XY:
2896
AN XY:
723940
show subpopulations
African (AFR)
AF:
0.000331
AC:
11
AN:
33214
American (AMR)
AF:
0.00170
AC:
75
AN:
44008
Ashkenazi Jewish (ASJ)
AF:
0.0000770
AC:
2
AN:
25966
East Asian (EAS)
AF:
0.0000253
AC:
1
AN:
39602
South Asian (SAS)
AF:
0.000678
AC:
58
AN:
85504
European-Finnish (FIN)
AF:
0.00440
AC:
235
AN:
53358
Middle Eastern (MID)
AF:
0.000522
AC:
3
AN:
5750
European-Non Finnish (NFE)
AF:
0.00486
AC:
5391
AN:
1109166
Other (OTH)
AF:
0.00339
AC:
204
AN:
60154
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
285
570
854
1139
1424
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
208
416
624
832
1040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00280
AC:
426
AN:
152330
Hom.:
2
Cov.:
33
AF XY:
0.00239
AC XY:
178
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.000866
AC:
36
AN:
41580
American (AMR)
AF:
0.00131
AC:
20
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4822
European-Finnish (FIN)
AF:
0.00414
AC:
44
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00467
AC:
318
AN:
68032
Other (OTH)
AF:
0.00331
AC:
7
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
21
43
64
86
107
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00345
Hom.:
1
Bravo
AF:
0.00250
TwinsUK
AF:
0.00539
AC:
20
ALSPAC
AF:
0.00493
AC:
19
ESP6500AA
AF:
0.00182
AC:
8
ESP6500EA
AF:
0.00419
AC:
36
ExAC
AF:
0.00250
AC:
304
EpiCase
AF:
0.00442
EpiControl
AF:
0.00385

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:3Benign:3
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

The FASTKD2 p.Lys50Arg variant was identified in 1 of 70 proband chromosomes (frequency: 0.0143) from individuals with ataxia (Pyle_2014_PMID: 25497598). The variant was identified in dbSNP (ID: rs141447598) and ClinVar (classified as likely benign by GeneDx and Invitae, and as uncertain significance by Center for Pediatric Genomic Medicine,Children's Mercy Hospital and Clinics, CeGaT Praxis fuer Humangenetik Tuebingen, and Mayo Clinic). The variant was identified in control databases in 761 of 279634 chromosomes (2 homozygous) at a frequency of 0.002721 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: European (Finnish) in 114 of 25062 chromosomes (freq: 0.004549), European (non-Finnish) in 535 of 128174 chromosomes (freq: 0.004174), Other in 23 of 7130 chromosomes (freq: 0.003226), Latino in 53 of 34698 chromosomes (freq: 0.001527), African in 17 of 24846 chromosomes (freq: 0.000684), South Asian in 15 of 29724 chromosomes (freq: 0.000505), Ashkenazi Jewish in 2 of 10180 chromosomes (freq: 0.000197), and East Asian in 2 of 19820 chromosomes (freq: 0.000101). The p.Lys50 residue is not conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and 2 of 4 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) predict a greater than 10% difference in splicing; this is not very predictive of pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign.

Oct 25, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 25, 2016
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

Sep 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

FASTKD2: BP4, BS2

Dec 10, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 25842392, 25842391, 25497598)

Dec 19, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mitochondrial complex IV deficiency, nuclear type 1 Uncertain:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance.

FASTKD2-related disorder Benign:1
May 11, 2021
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.063
BayesDel_addAF
Benign
-0.65
T
BayesDel_noAF
Benign
-0.71
CADD
Benign
4.7
DANN
Benign
0.72
DEOGEN2
Benign
0.00019
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.029
N
LIST_S2
Benign
0.48
T
M_CAP
Benign
0.0043
T
MetaRNN
Benign
0.0042
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.53
N
PhyloP100
0.61
PrimateAI
Benign
0.27
T
PROVEAN
Benign
0.46
N
REVEL
Benign
0.020
Sift
Benign
1.0
T
Sift4G
Benign
0.74
T
Polyphen
0.0020
B
Vest4
0.079
MVP
0.26
MPC
0.13
ClinPred
0.0026
T
GERP RS
0.69
Varity_R
0.030
gMVP
0.071
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141447598; hg19: chr2-207631566; API